A report published by the Centers for Disease Control and Prevention says there is no evidence that mRNA COVID vaccines cause fatal cardiac arrest or other deadly heart problems in teens and young adults. [ read more ]

SARS-CoV-2 Vaccine Significantly Extends Immune Response Half-Life

In a study that compared a SARS-CoV-2 mRNA-based primary vaccine series vs. an mRNA-based booster dose, the researchers found the booster dose elicits a 71 to 84 percent increase in the median humoral immune response half-life over that primary series. [ read more ]

Fourth Dose of COVID-19 Vaccine Increases Protection in Rheumatic Disease Patients

A new study suggests that the U.S. Centers for Disease Control and Prevention recommendation that patients receiving disease-modifying antirheumatic drugs receive a fourth dose of the mRNA vaccine in addition to the three-dose primary series to protect against COVID-19 saves lives and reduces hospitalizations among patients in this high-risk group. [ read more ]

New Vaccine Could Protect Against Coronaviruses That Have Yet to Emerge

Researchers at the University of Cambridge, University of Oxford and Caltech are developing a new “proactive vaccinology” that trains the body’s immune system to recognize several different coronaviruses — even those that have yet to emerge. [ read more ]

From Octapharma

The U.S. Food and Drug Administration has granted orphan drug exclusivity for Octapharma’s wilate (von Willebrand factor/coagulation factor VIII complex [human] lyophilized powder for solution for intravenous injection) for routine prophylaxis to reduce the frequency of bleeding episodes in adults and children 6 years of age and older with von Willebrand disease. [ read more ]

From CSL Behring

CSL Behring is discontinuing all sizes of Hizentra vials in the U.S. by the end of September 2024. The company is advising that all appropriate vial patients should be transitioned to Hizentra prefilled syringes (PFS), and new Hizentra patients should be started on PFS. [ Prescribers should contact their CSL Behring associate director of corporate accounts. ]

From CSL Behring

CSL Behring’s ZEMAIRA (alpha1-proteinase inhibitor [human]) is now available in 4 gram and 5 gram vials. Previously available only in a 1 gram vial, the new packaging is significant for the alpha-1 community as it will streamline the preparation process for ZEMAIRA and reduce waste. [ read more ]

• REGADENOSON (INTERNATIONAL MEDICATION SYSTEM)

REGADENOSON injection is a pharmacologic stress agent indicated for radionuclide myocardial perfusion imaging in patients unable to undergo adequate exercise stress. It is supplied as a sterile, preservative-free solution containing 0.08 mg/mL regadenoson in single-dose 5 mL prefilled syringes with a luer-lock fitting.

For more information log in to BioSupply

• GLUCAGON (AMPHASTAR PHARMACEUTICALS)

GLUCAGON for injection is indicated for the treatment of insulin coma or insulin reaction resulting from severe hypoglycemia (very low blood sugar). It is supplied as 1 mg glucagon for injection (as a sterile, lyophilized white to off-white powder) in a single-dose vial and 1 mL of diluent for glucagon in a prefilled syringe.

For more information log in to BioSupply

• MELPHALAN HYDROCHLORIDE (DR. REDDY'S LABORATORIES)

MELPHALAN HYDROCHLORIDE for injection is indicated for the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate. It is supplied in a carton containing one single-dose clear glass vial of freeze-dried melphalan hydrochloride equivalent to 50 mg melphalan and one 10 mL clear glass vial of sterile diluent.

For more information log in to BioSupply

• DAPSONE GEL (MAYNE PHARMA)

DAPSONE GEL 5% is indicated for the topical treatment of acne vulgaris. It is supplied in 60 gram and 90 gram laminate tubes.

For more information log in to BioSupply

• IXCHIQ (VALNEVA USA)

IXCHIQ is a vaccine indicated for the prevention of disease caused by chikungunya virus (CHIKV) in individuals 18 years of age and older who are at increased risk of exposure to CHIKV. It is supplied in a carton containing one single-dose vial of lyophilized antigen component, live, and one prefilled ungraduated syringe of sterile water diluent component (packaged without needles).

For more information log in to BioSupply

• HEPARIN SODIUM (MEITHEAL PHARMACEUTICALS)

HEPARIN SODIUM injection is an anticoagulant indicated for prophylaxis and treatment of venous thrombosis and pulmonary embolism; prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdominothoracic surgery or who, for other reasons, are at risk of developing thromboembolic disease; atrial fibrillation with embolization; treatment of acute and chronic consumptive coagulopathies (disseminated intravascular coagulation); prevention of clotting in arterial and cardiac surgery; prophylaxis and treatment of peripheral arterial embolism; and use as an anticoagulant in blood transfusion, extracorporeal circulation and dialysis procedures. It is supplied in single-dose vials in 1,000, 5,000 and 10,000 USP units per mL, and multi-dose vials in 10,000 USP units per 10 mL, 30,000 units per 30 mL, 50,000 units per 10 mL and 40,000 USP units per 4 mL, packaged in 25 vials per carton.

For more information log in to BioSupply

• HIBERIX (GLAXOSMITHKLINE)

HIBERIX is a vaccine indicated for active immunization for the prevention of invasive disease caused by Haemophilus influenza type b in children aged 6 weeks through 4 years (prior to fifth birthday). HIBERIX vial and vial presentation is supplied in a carton packaged without syringes or needles containing 10 single-dose vials of lyophilized antigen component and 10 single-dose vials of sterile saline diluent. HIBERIX vial and prefilled syringe presentation is supplied in a carton containing 10 single-dose vials of lyophilized antigen component and 10 single-dose prefilled ungraduated TIP-LOK syringes of sterile saline diluent packaged without needles.

For more information log in to BioSupply

• WINRHO SDF (KAMADA INC.)

WINRHO SDF is a Rho(D) immune globulin intravenous (IGIV; human) indicated for immune thrombocytopenic purpura (ITP) to raise platelet counts in Rho(D) positive, non-splenectomized children with chronic or acute ITP, adults with chronic ITP and children and adults with ITP secondary to HIV infection; and as a suppression of Rhesus (Rh) isoimmunization in pregnancy and other obstetric conditions in non-sensitized Rho(D) negative women with an Rh-incompatible pregnancy, including routine antepartum and postpartum Rh prophylaxis and Rh prophylaxis in obstetric complications or invasive procedures, and incompatible transfusions in Rho(D)-negative individuals transfused with blood components containing Rho(D)-positive red blood cells. It is supplied in cartons containing a single-dose vial of 600 IU (120 mcg), 1,500 IU (300 mcg), 2,500 IU (500 mcg), 5,000 IU (1,000 mcg) or 15,000 IU (3,000 mcg) anti-Rho(D) IGIV and a package insert.

For more information log in to BioSupply

• IVERMECTIN (MAYNE PHARMA)

IVERMECTIN cream is indicated for the treatment of inflammatory lesions of rosacea. It is supplied as a 45 gram 1% white to pale yellow cream in a laminated tube with a child-resistant cap.

For more information log in to BioSupply

• ISOTRETINOIN CAPSULES (MAYNE PHARMA)

ISOTRETINOIN CAPSULES are indicated for the treatment of severe recalcitrant nodular acne. They are supplied in boxes of 30 with three prescription packs of 10 mg, 20 mg, 30 mg or 40 mg capsules.

For more information log in to BioSupply

• BIJUVA (MAYNE PHARMA)

BIJUVA is a combination of an estrogen and progesterone indicated in a woman with a uterus for the treatment of moderate to severe vasomotor symptoms due to menopause. It is supplied as 0.5 mg/100 mg capsules and 1 mg/100 mg capsules in blister packages of 30.

For more information log in to BioSupply

• MELPHALAN HYDROCHLORIDE (APOTEX CORP)

MELPHALAN HYDROCHLORIDE for injection is indicated for the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate. It is supplied in a carton containing one single-dose clear glass vial of freeze-dried melphalan hydrochloride equivalent to 50 mg melphalan and one 10 mL clear glass vial of sterile diluent.

For more information log in to BioSupply

• CUPRIC CHLORIDE (EXELA PHARMA SCIENCES)

CUPRIC CHLORIDE injection, USP 0.4 mg/mL, is indicated for use as a supplement to intravenous solutions given for total parenteral nutrition to help maintain copper serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms. It is supplied in 10 mL plastic vials in cartons of 10 and 25.

For more information log in to BioSupply

• ZINC CHLORIDE (EXELA PHARMA SCIENCES)

ZINC CHLORIDE injection, USP 1 mg/mL, is indicated for use as a supplement to intravenous solutions given for total parenteral nutrition to help maintain zinc serum levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms. It is supplied in an individual 10 mL vial or in cartons of 25 10 mL vials.

For more information log in to BioSupply

• POTASSIUM ACETATE (EXELA PHARMA SCIENCES)

POTASSIUM ACETATE injection, USP 2 mEq/mL, is indicated as a source of potassium, for the addition to large volume intravenous fluids, to prevent or correct hypokalemia in patients with restricted or no oral intake; it is also useful as an additive for preparing specific intravenous fluid formulas when the needs of the patient cannot be met by standard electrolyte or nutrient solutions. It is supplied in 100 mEq/50 mL and 200 mEq/100 mL clear glass vials in cartons of one and 25.

For more information log in to BioSupply

• POTASSIUM PHOSPHATES (AMNEAL PHARMACEUTICALS)

POTASSIUM PHOSPHATES injection is a phosphorus replacement product indicated as a source of phosphorus in intravenous fluids to correct hypophosphatemia in adults and pediatric patients when oral or enteral replacement is not possible, insufficient or contraindicated; and for parenteral nutrition in adults and pediatric patients when oral or enteral nutrition is not possible, insufficient or contraindicated. It is supplied in 15 mmol/5 mL and 22 mEq/5 mL single-dose polypropylene vials in 5 and 25 units; 45 mmol/15 mL and 66 mEq/15 mL 20 mL single-dose polypropylene vials in 10 and 25 units; and 150 mmol/50 mL and 220 mEq/50 mL bulk package polypropylene vials in 10 and 25 units.

For more information log in to BioSupply

• GAMMAGARD LIQUID (BAXALTA)

GAMMAGARD LIQUID is an immune globulin infusion (human) indicated as a replacement therapy for primary humoral immunodeficiency in adult and pediatric patients 2 years of age or older; maintenance therapy to improve muscle strength and disability in adult patients with multifocal motor neuropathy; and therapy to improve neuromuscular disability and impairment in adult patients with chronic inflammatory demyelinating polyneuropathy. It is supplied in 10 mL, 25 mL, 50 mL, 100 mL, 200 mL and 300 mL single-use bottles.

For more information log in to BioSupply

• ZEMAIRA (CSL BEHRING)

ZEMAIRA is an alpha1-proteinase inhibitor (A₁-PI; human) indicated for chronic augmentation and maintenance therapy in adults with A₁-PI deficiency and clinical evidence of emphysema. It is supplied in single-dose vials containing 1,000 mg, 4,000 mg or 5,000 mg functionally active A₁-PI.

For more information log in to BioSupply

• COMIRNATY (PFIZER-BIONTECH)

COMIRNATY (mRNA) is a vaccine indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 12 years of age and older. It is supplied in cartons of 10 single-dose glass prefilled syringes, single-dose plastic prefilled syringes and single-dose vials.

For more information log in to BioSupply

• CARBOPLATIN (BPI LABS)

CARBOPLATIN injection is indicated for the initial treatment of advanced ovarian carcinoma in established combination with other approved chemotherapeutic agents, and for the palliative treatment of patients with ovarian carcinoma recurrent after prior chemotherapy, including patients who have been previously treated with cisplatin. It is supplied in 5 mL fill in 10 mL, 15 mL fill in 20 mL, 45 mL fill in 50 mL and 60 mL fill in 100 mL multiple-dose vials.

For more information log in to BioSupply

• YCANTH™ (VERRICA PHARMACEUTICALS)

YCANTH is indicated for the topical treatment of molluscum contagiosum in adult and pediatric patients 2 years of age and older. It is supplied in a sealed glass ampule contained within a single-use applicator and enclosed in a protective paperboard sleeve. Each ampule contains 7 mg/mL of YCANTH.

For more information log in to BioSupply

• NOVAVAX COVID-19 VACCINE (NOVAVAX, INC)

The Novavax COVID-19 Vaccine (Adjuvanted/Protein Subunit) is a vaccine indicated for active immunization to prevent coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 12 years of age and older. It is supplied in boxes of 10 doses of two 2.5mL-5 dose multi-dose vials.

For more information log in to BioSupply

• AREXVY (GLAXOSMITHKLINE)

AREXVY is a vaccine indicated for active immunization for the prevention of lower respiratory tract disease caused by respiratory syncytial virus in individuals 60 years of age and older. It is supplied as two components: a single-dose vial of lyophilized antigen component (powder) and a single-dose vial of adjuvant suspension component (liquid) (packaged without syringes or needles) in cartons of 10 vials.

For more information log in to BioSupply

• ABRYSVO (PFIZER INC.)

ABRYSVO is a vaccine indicated for active immunization for the prevention of lower respiration tract disease caused by respiratory syncytial virus in individuals 60 years of age and older. It is supplied in a kit that includes a vial of lyophilized antigen component, a prefilled syringe containing sterile water diluent component and a vial adapter in cartons of one, five and 10 kits.

For more information log in to BioSupply

• INDOCIN (ASSERTIO)

INDOCIN is a nonsteroidal anti-inflammatory drug indicated for moderate to severe rheumatoid arthritis, including acute flares of chronic disease; moderate to severe ankylosing spondylitis; moderate to severe osteoarthritis; acute painful shoulder (bursitis and/or tendinitis); and acute gouty arthritis. The 50 mg suppositories (indomethacin suppositories USP) are white, opaque and rectal supplied in boxes of 30.

For more information log in to BioSupply

• CALCIPOTRIENE FOAM (MAYNE PHARMA)

CALCIPOTRIENE FOAM is a vitamin D analog indicated for the topical treatment of plaque psoriasis of the scalp and body in adults and pediatric patients 4 years of age and older. It is supplied in a 60 gram aluminum can.

For more information log in to BioSupply

• DORYX MPC (MAYNE PHARMA)

DORYX MPC is a tetracycline-class drug indicated for the treatment of rickettsial infections; sexually transmitted infections; respiratory tract infections; specific bacterial infections; ophthalmic infections; anthrax, including inhalational anthrax (post-exposure); alternative treatment for selected infections when penicillin is contraindicated; adjunctive therapy in acute intestinal amebiasis and severe acne; and prophylaxis of malaria. The DORYX MPC (doxycycline hyclate delayed-release) 60 mg and 120 mg tablets are white, oval tablets containing yellow pellets and debossed with "D6" on one face and plain on the other. The 60 mg tablets are supplied in bottles of 60 and 120, and the 120 mg tablet is supplied in bottles of 30.

These products can be ordered from FFF Enterprises' BioSupply Online Ordering System or by calling
Wow! Customer Care at (800) 843-7477.

Current Medicare IVIG / SCIG Rates

Rates per gram are effective April 1, 2024, through June 30, 2024.

Resources

FFF customers may order the following complementary resources to help you with your practice: